Takeda Loses First Of Thousands Of U.S. Lawsuits Over Actos Drug
This article was originally published in PharmAsia News
Executive Summary
Takeda Pharmaceutical faces paying $6.5 million to a U.S. man to cover damages a court jury determined was caused by taking Actos (pioglitazone) to treat his diabetes.